Bullish Prospects For Alpha Tau Medical Ltd. (NASDAQ: DRTS) Shares In 2022

Alpha Tau Medical Ltd. (NASDAQ:DRTS) price on Wednesday, March 23, rose 14.15% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.78.

A look at the stock’s price movement, the close in the last trading session was $10.32, moving within a range at $10.35 and $14.65. The PE ratio in trailing twelve months stood at 72.27. Turning to its 52-week performance, $14.99 and $8.20 were the 52-week high and 52-week low respectively. Overall, DRTS moved 9.38% over the past month.

Alpha Tau Medical Ltd.’s market cap currently stands at around $1.02 billion.

Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s).

1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend DRTS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.

DRTS’s current price about 9.83% and 15.13% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.48, while 7-day volatility ratio is 18.63% and 17.82% in the 30-day chart. Further, Alpha Tau Medical Ltd. (DRTS) has a beta value of 0, and an average true range (ATR) of 1.82. Analysts have given the company’s stock an average 52-week price target of $18.00, forecast between a low of $18.00 and high of $18.00. Looking at the price targets, the low is -52.8% off current price level while to achieve the yearly target high, price needs to move -52.8%. Nonetheless, investors will most likely welcome a -52.8% jump to $18.00 which is the analysts’ median price.

In the market, a comparison of Alpha Tau Medical Ltd. (DRTS) and its peers suggest the former has performed considerably stronger. Data shows DRTS’s intraday price has changed 14.15% in last session and 21.19% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -1.23% and -1.29% respectively in the last trading.

If we refocus on Alpha Tau Medical Ltd. (NASDAQ:DRTS), historical trading data shows that trading volumes averaged 0.69 million over the past 10 days and 339.30K over the past 3 months. The company’s latest data on shares outstanding shows there are 34.38 million shares.

Current price change has pushed the stock 19.96% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DRTS stock continues to rise going into the next quarter.

Leave a Comment